As of 2025-09-18, the EV/EBITDA ratio of Codiak BioSciences, Inc. (CDAK) is 0.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CDAK's latest enterprise value is -21.30 mil USD. CDAK's TTM EBITDA according to its financial statements is -62.43 mil USD. Dividing these 2 quantities gives us the above CDAK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.4x - 20.4x | 17.2x |
| Forward P/E multiples | 11.5x - 26.6x | 15.8x |
| Fair Price | (11.21) - (14.88) | (11.96) |
| Upside | -19763.1% - -26203.0% | -21085.1% |
| Date | EV/EBITDA |